Intravitreal anti-VEGF agents, oral glucocorticoids, and laser photocoagulation combination therapy for macular edema secondary to retinal vein occlusion: preliminary report | Zendy

Xiao-Xiao Feng | Zendy; Cheng Li | Zendy; Wanwen Shao | Zendy; Yongguang Yuan | Zendy; Xiaobing Qian | Zendy; Qishan Zheng | Zendy; Yujie Li | Zendy; Qianying Gao | Zendy

Open Access

Intravitreal anti-VEGF agents, oral glucocorticoids, and laser photocoagulation combination therapy for macular edema secondary to retinal vein occlusion: preliminary report

Author(s) -

Xiao-Xiao Feng,

Cheng Li,

Wanwen Shao,

Yongguang Yuan,

Xiaobing Qian,

Qishan Zheng,

Yujie Li,

Qianying Gao

Publication year - 2018

Publication title -

international journal of ophthalmology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.634

H-Index - 29

eISSN - 2227-4898

pISSN - 2222-3959

DOI - 10.18240/ijo.2018.03.13

Subject(s) - medicine , macular edema , retinal vein , ophthalmology , central retinal vein occlusion , branch retinal vein occlusion , bevacizumab , occlusion , ranibizumab , retinal , vegf receptors , surgery , chemotherapy

To evaluate the efficacy and safety of combined anti-vascular endothelial growth factor (VEGF) agents, oral glucocorticoid, and laser photocoagulation therapy for macular edema (ME) secondary to retinal vein occlusion (RVO).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research